Tall stature in familial glucocorticoid deficiency

Lucila L K Elias, Angela Huebner, Louise A. Metherell, Atilio Canas, Gary L. Warne, Maria L. Manca Bitti, Stefano Cianfarani, Peter E. Clayton, Martin O. Savage, Adrian J L Clark

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

OBJECTIVE: Familial glucocorticoid deficiency (FGD) has frequently been associated with tall stature in affected individuals. The clinical, biochemical and genetic features of five such patients were studied with the aim of clarifying the underlying mechanisms of excessive growth in these patients. PATIENTS AND METHODS: Five patients with a clinical diagnosis of FGD are described in whom the disorder resulted from a variety of novel or previously described missense or nonsense mutations of the ACTH receptor (MC2-R). All patients demostrated excessive linear growth over that predicted from parental indices and increased head circumference. RESULTS: Growth hormone and IGF-I-values were normal. Growth charts suggest that the excessive growth is reduced to normal following the introduction of glucocorticoid replacement. A characteristic facial appearance including hypertelorism, marked epicanthic folds and prominent frontal bossing was noted. CONCLUSIONS: These findings indicate that ACTH resistance resulting from a defective ACTH receptor may be associated with abnormalities of cartilage and/or bone growth independently of the GH-IGF-I axis, but probably dependent on ACTH actions through other melanocortin receptors.

Original languageEnglish
Pages (from-to)423-430
Number of pages8
JournalClinical Endocrinology
Volume53
Issue number4
DOIs
Publication statusPublished - 2000

Fingerprint

Glucocorticoids
Corticotropin Receptors
Insulin-Like Growth Factor I
Growth
Melanocortin Receptors
Growth Charts
Hypertelorism
Nonsense Codon
Bone Development
Missense Mutation
Adrenocorticotropic Hormone
Growth Hormone
Cartilage
Molecular Biology
Reference Values
Head

ASJC Scopus subject areas

  • Endocrinology

Cite this

Elias, L. L. K., Huebner, A., Metherell, L. A., Canas, A., Warne, G. L., Manca Bitti, M. L., ... Clark, A. J. L. (2000). Tall stature in familial glucocorticoid deficiency. Clinical Endocrinology, 53(4), 423-430. https://doi.org/10.1046/j.1365-2265.2000.01122.x

Tall stature in familial glucocorticoid deficiency. / Elias, Lucila L K; Huebner, Angela; Metherell, Louise A.; Canas, Atilio; Warne, Gary L.; Manca Bitti, Maria L.; Cianfarani, Stefano; Clayton, Peter E.; Savage, Martin O.; Clark, Adrian J L.

In: Clinical Endocrinology, Vol. 53, No. 4, 2000, p. 423-430.

Research output: Contribution to journalArticle

Elias, LLK, Huebner, A, Metherell, LA, Canas, A, Warne, GL, Manca Bitti, ML, Cianfarani, S, Clayton, PE, Savage, MO & Clark, AJL 2000, 'Tall stature in familial glucocorticoid deficiency', Clinical Endocrinology, vol. 53, no. 4, pp. 423-430. https://doi.org/10.1046/j.1365-2265.2000.01122.x
Elias LLK, Huebner A, Metherell LA, Canas A, Warne GL, Manca Bitti ML et al. Tall stature in familial glucocorticoid deficiency. Clinical Endocrinology. 2000;53(4):423-430. https://doi.org/10.1046/j.1365-2265.2000.01122.x
Elias, Lucila L K ; Huebner, Angela ; Metherell, Louise A. ; Canas, Atilio ; Warne, Gary L. ; Manca Bitti, Maria L. ; Cianfarani, Stefano ; Clayton, Peter E. ; Savage, Martin O. ; Clark, Adrian J L. / Tall stature in familial glucocorticoid deficiency. In: Clinical Endocrinology. 2000 ; Vol. 53, No. 4. pp. 423-430.
@article{031220c202d948dc86b0a395899afdbb,
title = "Tall stature in familial glucocorticoid deficiency",
abstract = "OBJECTIVE: Familial glucocorticoid deficiency (FGD) has frequently been associated with tall stature in affected individuals. The clinical, biochemical and genetic features of five such patients were studied with the aim of clarifying the underlying mechanisms of excessive growth in these patients. PATIENTS AND METHODS: Five patients with a clinical diagnosis of FGD are described in whom the disorder resulted from a variety of novel or previously described missense or nonsense mutations of the ACTH receptor (MC2-R). All patients demostrated excessive linear growth over that predicted from parental indices and increased head circumference. RESULTS: Growth hormone and IGF-I-values were normal. Growth charts suggest that the excessive growth is reduced to normal following the introduction of glucocorticoid replacement. A characteristic facial appearance including hypertelorism, marked epicanthic folds and prominent frontal bossing was noted. CONCLUSIONS: These findings indicate that ACTH resistance resulting from a defective ACTH receptor may be associated with abnormalities of cartilage and/or bone growth independently of the GH-IGF-I axis, but probably dependent on ACTH actions through other melanocortin receptors.",
author = "Elias, {Lucila L K} and Angela Huebner and Metherell, {Louise A.} and Atilio Canas and Warne, {Gary L.} and {Manca Bitti}, {Maria L.} and Stefano Cianfarani and Clayton, {Peter E.} and Savage, {Martin O.} and Clark, {Adrian J L}",
year = "2000",
doi = "10.1046/j.1365-2265.2000.01122.x",
language = "English",
volume = "53",
pages = "423--430",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Tall stature in familial glucocorticoid deficiency

AU - Elias, Lucila L K

AU - Huebner, Angela

AU - Metherell, Louise A.

AU - Canas, Atilio

AU - Warne, Gary L.

AU - Manca Bitti, Maria L.

AU - Cianfarani, Stefano

AU - Clayton, Peter E.

AU - Savage, Martin O.

AU - Clark, Adrian J L

PY - 2000

Y1 - 2000

N2 - OBJECTIVE: Familial glucocorticoid deficiency (FGD) has frequently been associated with tall stature in affected individuals. The clinical, biochemical and genetic features of five such patients were studied with the aim of clarifying the underlying mechanisms of excessive growth in these patients. PATIENTS AND METHODS: Five patients with a clinical diagnosis of FGD are described in whom the disorder resulted from a variety of novel or previously described missense or nonsense mutations of the ACTH receptor (MC2-R). All patients demostrated excessive linear growth over that predicted from parental indices and increased head circumference. RESULTS: Growth hormone and IGF-I-values were normal. Growth charts suggest that the excessive growth is reduced to normal following the introduction of glucocorticoid replacement. A characteristic facial appearance including hypertelorism, marked epicanthic folds and prominent frontal bossing was noted. CONCLUSIONS: These findings indicate that ACTH resistance resulting from a defective ACTH receptor may be associated with abnormalities of cartilage and/or bone growth independently of the GH-IGF-I axis, but probably dependent on ACTH actions through other melanocortin receptors.

AB - OBJECTIVE: Familial glucocorticoid deficiency (FGD) has frequently been associated with tall stature in affected individuals. The clinical, biochemical and genetic features of five such patients were studied with the aim of clarifying the underlying mechanisms of excessive growth in these patients. PATIENTS AND METHODS: Five patients with a clinical diagnosis of FGD are described in whom the disorder resulted from a variety of novel or previously described missense or nonsense mutations of the ACTH receptor (MC2-R). All patients demostrated excessive linear growth over that predicted from parental indices and increased head circumference. RESULTS: Growth hormone and IGF-I-values were normal. Growth charts suggest that the excessive growth is reduced to normal following the introduction of glucocorticoid replacement. A characteristic facial appearance including hypertelorism, marked epicanthic folds and prominent frontal bossing was noted. CONCLUSIONS: These findings indicate that ACTH resistance resulting from a defective ACTH receptor may be associated with abnormalities of cartilage and/or bone growth independently of the GH-IGF-I axis, but probably dependent on ACTH actions through other melanocortin receptors.

UR - http://www.scopus.com/inward/record.url?scp=0033794585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033794585&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2265.2000.01122.x

DO - 10.1046/j.1365-2265.2000.01122.x

M3 - Article

C2 - 11012566

AN - SCOPUS:0033794585

VL - 53

SP - 423

EP - 430

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 4

ER -